Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

Journal of Virology

Volumn 83, Issue 15, 2009, Pages 7649-7658

  Chang, J Judy ^a   Sirivichayakul, Sunee ^b   Avihingsanon, Anchalee ^b   Thompson, Alex J V ^c,d   Revill, Peter ^c   Iser, David ^c,d,f   Slavin, John ^d   Buranapraditkun, Supranee ^b   Marks, Pip ^e   Matthews, Gail ^e   Cooper, David A ^e   Kent, Stephen J ^a,f   Cameron, Paul U ^f,g   Sasadeusz, Joe ^f,h   Desmond, Paul ^d   Locarnini, Stephen ^c   Dore, Gregory J ^e   Ruxrungtham, Kiat ^b   Lewin, Sharon R ^a,f,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STAINING; T LYMPHOCYTE; VIRUS REPLICATION;

ADULT; AGED; CYTOKINES; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

CERCOPITHECINE HERPESVIRUS 1; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67650866564     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00183-09     Document Type: Article

References (70)

1. + cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J. Infect. Dis. 191:702-709.
2. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204:2473-2485.
3. Anonymous. 1994. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15-20.
4. + T cell efficacy in vaccination and disease. Nat. Med. 14:623-628.
5. Aye, T. T., A. Bartholomeusz, T. Shaw, S. Bowden, A. Breschkin, J. McMillan, P. Angus, and S. Locarnini. 1997. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J. Hepatol. 26:1148-1153.
6. Balagopal, A., F. H. Philp, J. Astemborski, T. M. Block, A. Mehta, R. Long, G. D. Kirk, S. H. Mehta, A. L. Cox, D. L. Thomas, and S. C. Ray. 2008. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 135:226-233.
7. Banerjee, R., K. Sperber, T. Pizzella, and L. Mayer. 1992. Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha. AIDS 6:1127-1131.
8. Bedossa, P., T. Poynard, et al. 1996. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289-293.
9. +-T-cell-deficient mice. J. Virol. 76:12388-12393.
10. + T cell responses by intracellular cytokine production. Immunol. Lett. 79:117-125.
11. + T cells. Blood 107:4781-4789.
12. Bica, I., B. McGovern, R. Dhar, D. Stone, K. McGowan, R. Scheib, and D. R. Snydman. 2001. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin. Infect. Dis. 32: 492-497.
13. Bonacini, M., S. Louie, N. Bzowej, and A. R. Wohl. 2004. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 18:2039-2045.
14. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, A. Bertoletti, and C. Ferrari. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225.
15. Chang, J. J., and S. R. Lewin. 2007. Immunopathogenesis of hepatitis B virus infection. Immunol. Cell Biol. 85:16-23.
16. Chang, J. J., A. J. Thompson, K. Visvanathan, S. J. Kent, P. U. Cameron, F. Wightman, P. Desmond, S. A. Locarnini, and S. R. Lewin. 2007. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46:1332-1340.
17. + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J. Virol. 79: 3038-3051.
18. Colin, J. F., D. Cazals-Hatem, M. A. Loriot, M. Martinot-Peignoux, B. N. Pham, A. Auperin, C. Degott, J. P. Benhamou, S. Erlinger, D. Valla, and P. Marcellin. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29:1306-1310.
19. Cooley, L., A. Ayres, A. Bartholomeusz, S. Lewin, S. Crowe, A. Mijch, S. Locarnini, and J. Sasadeusz. 2003. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. AIDS 17:1649-1657.
20. Cooley, L., and J. Sasadeusz. 2003. Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. J. Clin. Virol. 26:185-193.
21. Draenert, R., M. Altfeld, C. Brander, N. Basgoz, C. Corcoran, A. G. Wurcel, D. R. Stone, S. A. Kalams, A. Trocha, M. M. Addo, P. J. Goulder, and B. D. Walker. 2003. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J. Immunol. Methods 275:19-29.
22. Dunn, C., M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, E. Humphreys, S. Afford, D. H. Adams, A. Bertoletti, and M. K. Maini. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204:667-680.
23. Fang, C. T., P. J. Chen, M. Y. Chen, C. C. Hung, S. C. Chang, A. L. Chang, and D. S. Chen. 2003. Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. J. Hepatol. 39:1028-1035.
24. Ferrari, C., A. Penna, A. Bertoletti, A. Valli, A. D. Antoni, T. Giuberti, A. Cavalli, M. A. Petit, and F. Fiaccadori. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:3442-3449.
25. Goepfert, P. A., A. Bansal, B. H. Edwards, G. D. Ritter, Jr., I. Tellez, S. A. McPherson, S. Sabbaj, and M. J. Mulligan. 2000. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J. Virol. 74:10249-10255.
26. Goldin, R. D., D. E. Fish, A. Hay, J. A. Waters, M. J. McGarvey, J. Main, and H. C. Thomas. 1990. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J. Clin. Pathol. 43:203-205.
27. + T cells in HIV/HCV versus HCV. Hepatology 40:125-132.
28. + T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550-5558.
29. Gruters, R. A., F. G. Terpstra, R. De Jong, C. J. Van Noesel, R. A. Van Lier, and F. Miedema. 1990. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 20:1039-1044.
30. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
31. Harari, A., S. Petitpierre, F. Vallelian, and G. Pantaleo. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103:966-972.
32. + T cells in human immunodeficiency virus/hepatitis C virus co-infected patients. Gut 55:1484-1487.
33. Hoffmann, C. J., and C. L. Thio. 2007. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect. Dis. 7:402-409.
34. + T lymphocytes. Nature 421:852-856.
35. Kellerman, S. E., D. L. Hanson, A. D. McNaghten, and P. L. Fleming. 2003. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J. Infect. Dis. 188:571-577.
36. + T-cell count in individuals coinfected with HIV-1. Blood 105:1170-1178.
37. Kim, A. Y., J. Schulze zur Wiesch, T. Kuntzen, J. Timm, D. E. Kaufmann, J. E. Duncan, A. M. Jones, A. G. Wurcel, B. T. Davis, R. T. Gandhi, G. K. Robbins, T. M. Allen, R. T. Chung, G. M. Lauer, and B. D. Walker. 2006. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 3:e492.
38. Konopnicki, D., A. Mocroft, S. de Wit, F. Antunes, B. Ledergerber, C. Katlama, K. Zilmer, S. Vella, O. Kirk, and J. D. Lundgren. 2005. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19:593-601.
39. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186:2057-2062.
40. Law, W. P., G. J. Dore, C. J. Duncombe, A. Mahanontharit, M. A. Boyd, K. Ruxrungtham, J. M. Lange, P. Phanuphak, and D. A. Cooper. 2003. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001. AIDS 17:2191-2199.
41. Law, W. P., C. J. Duncombe, A. Mahanontharit, M. A. Boyd, K. Ruxrungtham, J. M. Lange, P. Phanuphak, D. A. Cooper, and G. J. Dore. 2004. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 18: 1169-1177.
42. Lincoln, D., K. Petoumenos, and G. J. Dore. 2003. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med. 4:241-249.
43. + cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280.
44. Miailhes, P., M. A. Trabaud, P. Pradat, B. Lebouche, M. Chevallier, P. Chevallier, F. Zoulim, and C. Trepo. 2007. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin. Infect. Dis. 45: 624-632.
45. Milich, D. R., M. K. Chen, J. L. Hughes, and J. E. Jones. 1998. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. 160:2013-2021.
46. Nunez, M., B. Ramos, B. Diaz-Pollan, N. Camino, L. Martin-Carbonero, P. Barreiro, J. Gonzalez-Lahoz, and V. Soriano. 2006. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res. Hum. Retrovir. 22:842-848.
47. Ockenga, J., H. L. Tillmann, C. Trautwein, M. Stoll, M. P. Manns, and R. E. Schmidt. 1997. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J. Hepatol. 27:18-24.
48. Penna, A., F. V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
49. Piroth, L., D. Sene, S. Pol, I. Goderel, K. Lacombe, B. Martha, D. Rey, V. Loustau-Ratti, J. F. Bergmann, G. Pialoux, A. Gervais, C. Lascoux-Combe, F. Carrat, and P. Cacoub. 2007. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 Study). AIDS 21:1323-1331.
50. Puoti, M., A. Spinetti, A. Ghezzi, F. Donato, S. Zaltron, V. Putzolu, E. Quiros-Roldan, B. Zanini, S. Casari, and G. Carosi. 2000. Mortality for liver disease in patients with HIV infection: a cohort study. J. Acquir. Immune Defic. Syndr. 24:211-217.
51. Schlaak, J. F., G. Tully, H. F. Lohr, G. Gerken, and K. H. Meyer zum Buschenfelde. 1999. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin. Exp. Immunol. 115:508-514.
52. Schlaak, J. F., G. Tully, H. F. Lohr, G. Gerken, and K. H. Meyer zum Buschenfelde. 1999. The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. J. Hepatol 30:353-358.
53. + T cells in chronic human immunodeficiency virus infection. Blood 96:3094-3101.
54. Sprengers, D., R. G. van der Molen, J. G. Kusters, B. Hansen, H. G. Niesters, S. W. Schalm, and H. L. Janssen. 2006. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B. J. Med. Virol. 78:561-568.
55. Su, F., and R. J. Schneider. 1997. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 94:8744-8749.
56. + T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS. AIDS Res. Hum. Retrovir. 17:1749-1756.
57. Tang, T. J., H. L. Janssen, J. G. Kusters, R. A. de Man, S. W. Schalm, and J. Kwekkeboom. 2003. The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique. FEMS Immunol. Med. Microbiol. 39:69-72.
58. Tang, T. J., J. Kwekkeboom, J. D. Laman, H. G. Niesters, P. E. Zondervan, R. A. De Man, S. W. Schalm, and H. L. Janssen. 2003. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J. Viral Hepat. 10:159-167.
59. Thio, C. L., E. C. Seaberg, R. Skolasky, Jr., J. Phair, B. Visscher, A. Munoz, and D. L. Thomas. 2002. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921-1926 .
60. Trimble, L. A., and J. Lieberman. 1998. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 91:585-594 .
61. UNAIDS. 2006. AIDS epidemic update: Dec 2006. http://www.unaids. org/en/HIV-data/epi2006/default.asp.
62. Vali, B., F. Y. Yue, R. B. Jones, P. M. Sheth, R. Kaul, M. R. Betts, D. Wong, C. Kovacs, M. Loutfy, A. Common, R. Halpenny, and M. A. Ostrowski. 2008. HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection. PLoS ONE 3:e3454.
63. Visvanathan, K., N. A. Skinner, A. J. Thompson, S. M. Riordan, V. Sozzi, R. Edwards, S. Rodgers, J. Kurtovic, J. Chang, S. Lewin, P. Desmond, and S. Locarnini. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45:102-110.
64. Vlahakis, S. R., A. Villasis-Keever, T. S. Gomez, G. D. Bren, and C. V. Paya. 2003. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J. Infect. Dis. 188:1455-1460.
65. Weber, R., C. A. Sabin, N. Friis-Moller, P. Reiss, W. M. El-Sadr, O. Kirk, F. Dabis, M. G. Law, C. Pradier, S. De Wit, B. Akerlund, G. Calvo, A. Monforte, M. Rickenbach, B. Ledergerber, A. N. Phillips, and J. D. Lundgren. 2006. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 166:1632-1641.
66. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 78:5707-5719.
67. Weinberg, A., D. A. Wohl, R. J. Barrett, and C. van der Horst. 2001. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 184:707-712.
68. WHO. 2002. Hepatitis B. http://www.who.int/csr/disease/hepatitis/ HepatitisB-whocdscsrlyo2002-2.pdf.
69. Zhou, J., G. J. Dore, F. Zhang, P. L. Lim, and Y. M. Chen. 2007. Hepatitis B and C virus coinfection in the TREAT Asia HIV Observational Database. J. Gastroenterol. Hepatol. 22:1510-1518.
70. Zimmerli, S. C., A. Harari, C. Cellerai, F. Vallelian, P. A. Bart, and G. Pantaleo. 2005. HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. USA 102:7239-7244.